DDL provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation. DDL2017 will have five themed sessions each with a combination of invited and submitted lectures given by experts in the field of inhalation and students working to advance respiratory science.
TTP will be exhibiting, on stand 430, at the Drug Delivery to the Lungs Conference, 6th - 8th December 2017 at the Edinburgh International Conference Centre.
Looking ahead it won’t be about the drug or even the combination of drug and device; with the introduction of value-based healthcare the way in which therapies are evaluated will change. TTP understands this complexity and we are working with our clients to engineer outcomes.
Visit the DDL website here.
Find out more about TTP | engineering outcomes here.